Everyone knows opioid painkillers have been in the news for quite some time, as these drugs have been found to be highly addictive and abused. Recently it was announced that Endo would pull Opana ER from the market after the FDA asked the pharmaceutical manufacturer to pull the drug about 30 days ago. Opana ER, or oxymorphone hydrochloride, is reported …
Psoriasis is a common skin condition with no known cure at the moment, however India’s largest drug manufacturer, Sun Pharmaceutical, and South Korea-based Samsung BioLogics have recently signed an agreement regarding the manufacture of Tildrakizumab in experimental treatment of this frustrating condition. According to news reports, the FDA (U.S. Food & Drug Administration) and EMA (European Medicines Agency) are reviewing …
Everywhere we turn today, we hear news about the “opioid” crisis; lives have been impacted throughout the U.S. and North America as some who’ve taken opioids for pain management have become addicted, while others get their “fix” on the streets. Recently in pharma news, it was announced that Takeda Pharmaceuticals International AG will use an e-Lockout device that essentially limits …
StandUpPouches.net, an online supplier of flexible retail packaging solutions who helps small and medium-size businesses grow their brands and market through innovative pouches, recently announced their findings after performing research regarding baby food packaging. Partnering with Cint, an independent research firm, the survey involved more than 1,000 U.S. parents to get an idea of what type of baby food packaging …
Recently in pharma news, in a 9 – 0 ruling, the U.S. Supreme Court overturned a lower court’s decision that prevented Novartis from selling its biosimilar version of Neupogen, a drug made by California-based Amgen Inc. Prior to the ruling, biosimilar drugs (also referred to as “copycat” versions of other drugs) could not be put on the market until six …